- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 148 Pages
Global
From €3254EUR$3,613USD£2,811GBP
€3828EUR$4,250USD£3,307GBP
- Report
- January 2022
- 278 Pages
Global
From €3254EUR$3,613USD£2,811GBP
€3828EUR$4,250USD£3,307GBP
- Report
- January 2022
- 230 Pages
Global
From €4143EUR$4,600USD£3,580GBP
- Report
- January 2022
- 14 Pages
Europe
- Report
- January 2022
- 278 Pages
Global
From €3254EUR$3,613USD£2,811GBP
€3828EUR$4,250USD£3,307GBP
- Report
- November 2021
- 220 Pages
Global
From €2162EUR$2,400USD£1,868GBP
- Report
- November 2021
- 209 Pages
Global
From €3254EUR$3,613USD£2,811GBP
€3828EUR$4,250USD£3,307GBP
- Report
- October 2021
- 70 Pages
United States
From €982EUR$1,090USD£848GBP
- Report
- October 2021
- 180 Pages
United States
From €2252EUR$2,500USD£1,945GBP
From €3254EUR$3,613USD£2,811GBP
€3828EUR$4,250USD£3,307GBP
- Report
- September 2021
- 19 Pages
Thailand
From €825EUR$981USD£738GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- September 2021
- 40 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- July 2021
- 50 Pages
China
From €2342EUR$2,600USD£2,023GBP
- Report
- July 2021
- 50 Pages
China
From €2342EUR$2,600USD£2,023GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more